DrugPatentWatch Database Preview
Details for Patent: 8,367,649
Which drugs does patent 8,367,649 protect, and when does it expire?
Patent 8,367,649 protects KYBELLA and is included in one NDA.
Summary for Patent: 8,367,649
| Title: | Formulations of deoxycholic acid and salts thereof |
| Abstract: | The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5. |
| Inventor(s): | Hodge; Robert Emil (Thousand Oaks, CA), Webster; Jeffrey Douglas (Thousand Oaks, CA) |
| Assignee: | Kythera Biopharmaceuticals, Inc. (Calabasas, CA) |
| Application Number: | 13/323,605 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 8,367,649
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kythera Biopharms | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,367,649
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,724,356 | Formulations of deoxycholic acid and salts thereof | ➤ Sign Up |
| 8,101,593 | Formulations of deoxycholic acid and salts thereof | ➤ Sign Up |
| 9,186,364 | Formulations of deoxycholic acid and salts thereof | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
